Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. [electronic resource]
Producer: 20190102Description: 29-39 p. digitalISSN:- 1878-1705
- Animals
- Antineoplastic Agents, Immunological -- therapeutic use
- B7-H1 Antigen -- antagonists & inhibitors
- CTLA-4 Antigen -- antagonists & inhibitors
- Humans
- Immunotherapy -- methods
- Neoplasms -- drug therapy
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- T-Lymphocytes -- drug effects
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.